Skip to content
Artwork for Dr. John Campbell
EducationHealth & FitnessMedicine

Dr. John Campbell

Campbellteaching

Hello Everyone, My name is John Campbell and I am a retired Nurse Teacher and former clinical nurse based in England. I also do some teaching in Asia and Africa when time permits. These videos are to help students to learn the background to all forms of health care. My PhD focused on the development of open learning resources for nurses nationally and internationally. LinkedIn profile, https://www.linkedin.com/in/dr-john-campbell-5256223b/ Twitter, https://twitter.com/Johnincarlisle Disclaimer; These media including videos, book, e book, articles, podcasts are not peer-reviewed. They should never replace individual clinical judgement from your own health care provider. No media-based material on this channel is suitable for using as professional medical advice. All comments are also for educational purposed only and must never replace advice from your own health care provider

Play
  • 832 episodes
  • daily
  • Avg 24 min
  • English
Counted on this page — what you have heard stays on this device, so it is not something the list can be paged by.
  • October 16 · 21 min

    Encouraging high infection rate

    Most people in England have been naturally infected. Link to free download of my 2 textbooks Uploaded 23-04-22 http://159.69.48.3/ https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19/latestinsights 22 April 2022 27th April 2020 to 11th February 2022 70.7% in England are estimated to have had COVID-19 The estimated percentage of the community population (those not in hospitals, care homes or other institutional settings) that had COVID-19 was: 70.7% of the population (38.5 million people) in England 56.0% of the population (1.7 million people) in Wales 72.2% of the population (1.3 million people) in Northern Ireland 51.5% of the population (2.7 million people) in Scotland 27 April 2020 to 11 February 2022 for England 30 June 2020 to 11 February 2022 for Wales 27 July 2020 to 11 February 2022 for Northern Ireland 22 September 2020 to 11 February 2022 for Scotland Coronavirus (COVID-19) Infection Survey technical article: Cumulative incidence of the number of people who have tested positive for COVID-19, UK: 22 April 2022 https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsurveytechnicalarticlecumulativeincidenceofthenumberofpeoplewhohavetestedpositiveforcovid19uk/22april2022 https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/coronaviruscovid19infectionsurveycharacteristicsofpeopletestingpositiveforcovid19uk/30march2022#re-infections-with-covid-19-uk Number of people who have had at least one episode of coronavirus 27 April 2020 until 11 February 2022 N = 535,116 people in the UK Aged two years and over and were living in private households Each participant was regularly tested during the duration of their time in the study. Swabs were tested using polymerase chain reaction (PCR). We take all positive and negative tests in the survey and apply statistical modelling techniques to estimate the number of people who have had COVID-19 in the population, in each of the four UK nations for the duration of the survey. Daily prevalence and incidence estimated Incidence estimated from prevalence We do this using both positive and negative swab results Positivity (prevalence) from "first infection" episodes a new positive test occurs 120 days or more after an individual's first positive test in the survey, and their most recent prior test result was negative or, last positive test has been followed by four consecutive negative tests Incidence methodology Duration of testing positive varies from person Incidence and duration can be used to give prevalence Reinfections We retest the same people, regardless of whether they have symptoms, we can identify both infections and re-infections, and our data includes asymptomatic cases. Cambridge University modelling 20th February 2020 to 10th February 2022 https://www.mrc-bsu.cam.ac.uk/now-casting/nowcasting-and-forecasting-25th-february-2022/ Estimates 40.2 million people had COVID-19 in England 30% of all infections are re-infections. The risk of re-infection was approximately 10 times higher in the period when the Omicron variants were most common, compared with when the Delta variant was most common Learn more about your ad choices. Visit megaphone.fm/adchoices Learn more about your ad choices. Visit megaphone.fm/adchoices

  • October 16 · 1 hr 21 min

    End of age of deference

    In depth talk with Neil Oliver, Tim Kelly and John Campbell. Times have changed. This video contains many serious points for the serious viewer. Check out Neil's channel as well, https://www.youtube.com/@Neil-Oliver Follow Tim on X, https://x.com/DrTimothyKelly Uploaded 21-05-25 Learn more about your ad choices. Visit megaphone.fm/adchoices Learn more about your ad choices. Visit megaphone.fm/adchoices

  • October 16 · 17 min

    The Unknown Self, Useful psychology, Johari

    Useful psychology. The Johari Window and aspects of the self. Uploaded 07-06-25 Open Self Skills Attitudes Knowledge Enlarging will: Increases transparency More authentic relationships Fosters trust Collaboration Stronger connections Blind Self Others can see Self-unaware Non-verbal cues Habits / mannerisms Behavioural tendencies Reducing by: Improves self-awareness Achieved by: Seeking feedback Open to advice Willingness to learn Inhibited by: Pride Denial Hidden (Façade) Self Thoughts Feelings Fears Lusts Values Aspirations Insecurities Reduction by: Self-disclosure Honesty Strengthen relationships Improve emotional connections Inhibited by: Fear of judgment Vulnerability Embarrassments Unknown Self Latent talents Repressed emotions Subconscious beliefs Potential capabilities Reduction by: Self-reflection New experiences Challenges Unexpected circumstances Joseph Luft and Harrington Ingham (1955) Learn more about your ad choices. Visit megaphone.fm/adchoices Learn more about your ad choices. Visit megaphone.fm/adchoices

  • October 16 · 34 min

    Endemic equilibrium cometh

    Virus is close to reaching “endemic equilibrium” Update on Balira Uploaded 25-10-21 Link to original Wefeafwa video https://www.youtube.com/watch?v=mV7a9MMFbRg&t=15s If you would like to support our community health outreach in Uganda (100% of donations go directly to Wefwafwa) patreon:https://www.patreon.com/awmedicalvideos Donate: SENDWAVE/ WorldRemit /Western Union/Money Gram Mobile money number:+256785698803 Country: Uganda Registered name : Wefwafwa Andrew State: Eastern uganda Zip code:0000 Wallet Service provider:MTN City: Mbale city please email me when you send or to talk with me directly, wefandrew@gmail.com London School of Hygiene and Tropical Medicine https://www.telegraph.co.uk/news/2021/10/24/coronavirus-cases-slump-winter-say-scientists/ Imminent drops in infections Cases could fall to around 5,000 a day before Christmas Prof John Edmunds, Centre for the Mathematical Modelling of Infectious Diseases, LSHTM Member of SAGE Our model was projecting that cases would start to decline some time in the autumn. However, the model also suggests that cases may start to climb again in the spring, due to a combination of waning immunity and increased contacts Cases currently being driven by high case rates in children Virus is close to reaching “endemic equilibrium” Recent oscillations in case rates will soon level Rishi Sunak at the moment the data does not suggest that we should be immediately moving to 'Plan B Maggie Throup, UK vaccines minister 'Plan A' is working, situation where we need to be United States Pfizer for children, 5 to 11, FDA votes for EMU tomorrow From first half of November 2 shots, 3 weeks gap One third of adult dose 25,000 centres signed up for roll out 28 million children in demographic https://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-submit-initial-data-us-fda-pivotal https://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-announce-positive-topline-results https://www.businesswire.com/news/home/20210920005452/en/ https://www.fda.gov/media/153447/download Results are the first from a pivotal trial of any COVID-19 vaccine in children under 12 years of age In participants 5 to 11 years of age, the vaccine was safe, well tolerated and showed robust neutralizing antibody responses Phase 2/3 study United States, Finland, Poland, Spain Children 6 months to 11 years of age N = 2,268 5 to 11 years of age Received a 10 µg dose level in a two-dose regimen Strong SARS-CoV-2–neutralizing antibody response, one month after the second dose Continue to accumulate the safety and efficacy data Topline readouts for the other two age cohorts from the trial, soon Children 2-5 years of age Children 6 months to 2 years of age About the Phase 1/2/3 Trial in Children N = 4,500 children ages 6 months to 11 years More than 90 clinical trial sites Children under 5 received a 3 µg dose Trial enrolled children with or without prior evidence of SARS-CoV-2 infection ONS https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19/latestinsights Reduction in self-reported long COVID after vaccination https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19vaccinationandselfreportedlongcovidintheuk/25october2021 Identified themselves as experiencing persistent symptoms 12 weeks after first infection A first vaccine dose was associated with an initial 13% decrease in self-reported long COVID, and a further 9% sustained decrease after receiving the second vaccination No evidence of differences in self-reported between Oxford/AstraZeneca vaccine, compared to Pfizer/BioNTech or Moderna vaccines UK, 30 June to 17 October 2021 Practice falls below thinking https://www.ons.gov.uk/peoplepopul Learn more about your ad choices. Visit megaphone.fm/adchoices

  • October 16 · 15 min

    Spike and disorder

    Premiere: Inside mRNA Vaccines https://www.youtube.com/watch?v=BZrJraN2nOQ https://www.youtube.com/watch?v=BZrJraN2nOQ Inside mRNA vaccines https://www.insidemrnavaccines.com/ Filmmaker: Erik Tangsoo Learn more about your ad choices. Visit megaphone.fm/adchoices

  • October 16 · 25 min

    UK, 4.49 m cases now

    Symptomatic cases as reported from the symptom tracker data, John’s free text books, Uploaded 02-04-22 Link to free download of my 2 textbooks http://159.69.48.3/ 1 in 15 has COVID in new record high https://covid.joinzoe.com/post/1-in-15-have-covid-in-new-record-high New daily symptomatic cases of COVID in the UK, 349,011 Increase of 7% from 324,954 reported last week UK R-value, 1.1 Scotland, 1.0 Prevalence One in 15, currently have symptomatic COVID 840,000 weekly contributors 70,779 recent swab tests done on symptomatic cases Professor Tim Spector https://www.youtube.com/watch?v=-DvAjTfiG6E&t=756s While COVID cases continue to soar to all-time highs, the rate of increase is showing signs of slowing down. Data shows LFTs are almost 80% effective in detecting positive cases, (20% false negatives) 97% accurate in identifying negative cases, (3% false positives) COVID-19 infections highest in England and Wales since survey began https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19/latestinsights#infections Percentage testing positive continues to rise in England and Wales, highest level ever Week ending 26 March 2022 4,122,700 in England (7.56%) 212,000 in Wales (6.97%) Highest since 6.85% 6th January 2022 Coronavirus antibodies 96.6% of secondary school age (46.6%) 62.4% of primary school age Deaths involving COVID-19 increase slightly Week ending 18 March 2022 Deaths in the UK involving coronavirus 826 5 more than the previous week, accounting for around 1 in every 15 deaths (6.6%) Total deaths registered in the UK Most recent week, 12,473 0.3% below the five-year average Of the 683 deaths registered in England and Wales where “novel coronavirus (COVID-19)” was mentioned 65.3% (446 deaths) had this recorded as the underlying cause of death, up from 62.1% in the previous week 13 March 2020 to 18 March 2022 126,529 excess deaths above the five-year average in England and Wales Ivermectin https://www.wsj.com/articles/ivermectin-didnt-reduce-covid-19-hospitalizations-in-largest-trial-to-date-11647601200?mod=djemalertNEWS https://flccc.substack.com/p/independent-research-is-our-only?s=r https://www.nejm.org/doi/full/10.1056/NEJMoa2115869 1 in 15 has COVID in new record high https://covid.joinzoe.com/post/1-in-15-have-covid-in-new-record-high New daily symptomatic cases of COVID in the UK, 349,011 Increase of 7% from 324,954 reported last week UK R-value, 1.1 Scotland, 1.0 Prevalence One in 15, currently have symptomatic COVID 840,000 weekly contributors 70,779 recent swab tests done on symptomatic cases Professor Tim Spector https://www.youtube.com/watch?v=-DvAjTfiG6E&t=756s While COVID cases continue to soar to all-time highs, the rate of increase is showing signs of slowing down. Data shows LFTs are almost 80% effective in detecting positive cases, (20% false negatives) 97% accurate in identifying negative cases, (3% false positives) COVID-19 infections highest in England and Wales since survey began https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19/latestinsights#infections Percentage testing positive continues to rise in England and Wales, highest level ever Week ending 26 March 2022 4,122,700 in England (7.56%) 212,000 in Wales (6.97%) Highest since 6.85% 6th January 2022 Coronavirus antibodies 96.6% of secondary school age (46.6%) 62.4% of primary school age Deaths involving COVID-19 increase slightly Week ending 18 March 2022 Deaths in the UK involving coronavirus 826 5 more than the previous week, accounting for around 1 in every 15 deaths (6.6%) Total deaths registered in the UK Most recent week, 12,473 0.3% below the five-year average Of the 683 deaths registered in England and Wales where “no Learn more about your ad choices. Visit megaphone.fm/adchoices

  • October 16 · 25 min

    NIH, Wuhan were working on monkeypox

    Wuhan Institute of Virology published on monkeypox research 3 months ago, NIH also have been researching monkeypox treatment Uploaded 31-05-22 https://reporter.nih.gov/search/sLt357_GeUyXtIUvUOY0MQ/project-details/10506292 Total funding, $9,824,009 The funding supports a clinical trial to identify effective treatments for monkeypox A re-emerging pathogen A disease of epidemic potential Causes significant morbidity and can result in death Human cases have been increasing in sub-Saharan Africa since 2000 Sporadic outbreaks outside of Africa have occurred Similarity between MPXV and the variola virus, coupled with concerns about the potential of the variola virus as a potential bioterrorism agent, have placed monkeypox treatments at the forefront of public health and scientific research agendas in many countries. Article in Virologica Sinica? https://www.sciencedirect.com/science/article/pii/S1995820X22000414 Efficient assembly of a large fragment of monkeypox virus genome as a qPCR template using dual-selection based transformation-associated recombination (Feb 2022) Since MPXV infection has never been associated with an outbreak in China, the viral genomic material required for qPCR detection is unavailable. Using viral DNA recombinations Transformation-associated recombination (TAR), to assemble large DNA constructs A 55-kb genomic fragment of monkeypox virus in VL6-48B (yeast cells) What is Virologica Sinica? https://www.sciencedirect.com/journal/virologica-sinica/about/aims-and-scope Virologica Sinica, the official journal of Chinese Society for Microbiology, will serve as a platform for the communication and exchange of academic information and ideas in an international context. Discussion section However, this DNA assembly tool applied in virological research could also raise potential security concerns, especially when the assembled product contains a full set of genetic material that can be recovered into a contagious pathogen. Recently, a group of scientists was funded by a biotech company to synthesize a full-length horsepox virus genome and recover it into an infectious virus (Noyce et al., 2018). Not surprisingly, such a controversial achievement has received enormous attention and raised global debate on its biosecurity implications (DiEuliis et al., 2017; Koblentz, 2017, 2018; DiEuliis and Gronvall, 2018). In this study, although a full-length viral genome would be the ideal reference template for detecting MPXV by qPCR, we only sought to assemble a 55-kb viral fragment, less than one-third of the MPXV genome. This assembly product is fail-safe by virtually eliminating any risk of recovering into an infectious virus while providing multiple qPCR targets for detecting MPXV or other Orthopoxviruses (Li et al., 2010). Our world in data monkeypox https://ourworldindata.org/explorers/monkeypox Spain and Belgium ‘gay events’ UK Cases, + 11 = 190 20,000 doses of a smallpox vaccine offered to close contacts of those diagnosed with monkeypox reduce the risk of symptomatic infection and severe illness Dr Rosamund Lewis, WHO It's very important to describe this because it appears to be an increase in a mode of transmission that may have been under-recognised in the past unfortunate if monkeypox exploit the immunity gap left by smallpox 40 years ago there is still a window to close the outbreak Learn more about your ad choices. Visit megaphone.fm/adchoices Learn more about your ad choices. Visit megaphone.fm/adchoices

  • October 16 · 36 min

    New disease

    Thank you to Mr. John O’Looney of Milton Keynes Family Funeral Services, https://www.mkffs.co.uk/ Uploaded 09-02-24 Learn more about your ad choices. Visit megaphone.fm/adchoices Learn more about your ad choices. Visit megaphone.fm/adchoices

  • October 7 · 29 min

    Northern hemisphere good news

    Covis symptom tracker data Uploaded 02-05-22 https://www.youtube.com/watch?v=9qsd4p8TWvI&t=33s Cases down in all age groups and regions R = 0.8 One in 20 people currently infected (government cases about 20% of infections) https://coronavirus.data.gov.uk Symptoms Runny nose, 84% Fatigue, 72% Sore throat, 69% Sneezing, 69% Headache, 68% Persistent cough, 57% Hoarse, 49% Chills or shivers, 37% Joint pains, 34% Dizzy, 32% Fever, 31% Brain fog, 29% Sore eyes, 27% Altered smell, 26% Muscle pains 23% Lower back pain, 23% Swollen glands, 21% Skipped meals, 19% Ear ringing, (Tinnitus) 19% Diarrhoea Tinnitus N = 5,000 Couple of days Exacerbation Moderate / intermittent 50% of weeks or months Cancer, menopause, childhood viral hepatitis Learn more about your ad choices. Visit megaphone.fm/adchoices Learn more about your ad choices. Visit megaphone.fm/adchoices

  • October 7 · 13 min

    John develops covid .. again

    Sadly, and completely unnecessarily, this has become our common shared experience Learn more about your ad choices. Visit megaphone.fm/adchoices

  • October 7 · 14 min

    Wonderful talk with GB News and Bev Turner

    Thank you GB News and Bev, you made me feel most welcome. Great series of questions. So good to talk face to face rather than via the internet. Learn more about your ad choices. Visit megaphone.fm/adchoices

  • October 7 · 40 min

    Vaccine injury, film maker and scientist

    Mr Dean Rainey and Dr. David Speicher. Watch the full documentary on YouTube https://www.youtube.com/watch?v=XwjDeRglkwg Uploaded 28-06-25 Learn more and support ‘Why can’t we talk about this’ https://raineymedia.com/video-store/ Please Support Our Film via: E-Transfer: dean_rainey@yahoo.ca PAYPAL: deanrainey@raineymedia.com Buy My A Coffee: https://buymeacoffee.com/raineymedia SNAIL MAIL: Rainey Media, PO Box 5, Delhi PO Main, ON, N4B 2W8 Canada To book your own screening: deanrainey@raineymedia.com Learn more about your ad choices. Visit megaphone.fm/adchoices Learn more about your ad choices. Visit megaphone.fm/adchoices

Showing 821–832 of 832 episodes